Theme Templates, —
Articles by Theme Templates
Recent Posts
- Long-term ZYN002 eases irritability in fragile X patients: Trial data
- Fragile X treatment KER-0193 found safe in healthy adults in trial
- SPG601 found to reduce measure of abnormal brain activity in fragile X
- SPG601 granted FDA fast track designation for fragile X
- Researchers to study FXTAS risk in people with FMR1 premutation
- Mirum plans 2025 Phase 2 trial testing fragile X treatment
- New company Aptadir to develop gene reactivating therapy for fragile X
- FRAXA, Marvel Biosciences team up to test therapy in fragile X animal models
- Protocols for US trials of zatolmilast amended to increase accessibility
- Several initiatives on tap for Fragile X Awareness Month in July